ArticleEuroasian journal of hepato-gastroenterology
Frequency and Predictors of Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia.
Article in Euroasian journal of hepato-gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Functional dyspepsia (FD) is a disorder of gut-brain interaction characterized by chronic upper gastrointestinal symptoms without a structural explanation for those complaints. Small intestinal bacterial overgrowth (SIBO) has been proposed as one mechanism that may contribute to symptoms in a subset of affected patients. We assessed how often SIBO was present in FD and examined variables associated with SIBO positivity. Materials and methods: This case-control study was conducted at a tertiary gastroenterology center in India. Thirty adults fulfilling Rome IV criteria for FD and 30 age- and sex-matched healthy controls were enrolled. All participants underwent glucose hydrogen-methane breath testing. Clinical and laboratory variables were compared between SIBO-positive and SIBO-negative patients, followed by multivariable analysis. Results: Among patients with FD, epigastric pain syndrome was the most frequent subtype (53.33), followed by overlap FD (43.33) and postprandial distress syndrome (3.3%). Small intestinal bacterial overgrowth was identified more often in cases than in controls [8/30 (26.6%) vs 1/30 (3.3%); Conclusion: Compared with healthy controls, patients with FD had a higher prevalence of SIBO. Although a few symptom-related variables tracked with SIBO on univariate testing, no independent clinical predictor was established. Larger studies are required before symptom-based selection of FD patients for SIBO testing can be advised.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.